Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04160429 · ClinicalTrials.gov registry record

Biospecimen Analysis in Detecting Chemical Concentrations in Patients With Chronic or Infectious Diseases Receiving Meditations

A clinical trial of Chronic Disease and Infectious Disorder, sponsored by City of Hope Medical Center.

Recruiting
Registry status
100
Enrollment target
1
Study location

NCT04160429: Recruiting study of Chronic Disease and Infectious Disorder, sponsored by City of Hope Medical Center.

NCT04160429 is a study of Chronic Disease and Infectious Disorder that is actively recruiting participants, run by City of Hope Medical Center. The registered enrollment target is 100 participants, below the 89,941-participant average among 48 other Chronic Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04160429, a study of Chronic Disease and Infectious Disorder, is actively recruiting participants, sponsored by City of Hope Medical Center.

RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

This trial collects and analyzes sweat and saliva samples compared to blood in detecting chemical concentrations in the body in patients with chronic or infectious diseases receiving medications. Wearable sweat sensors are capable of monitoring electrolytes and metabolites (sodium, potassium, glucose, lactate, etc.) for health monitoring and disease diagnosis. Designing wearable sweat sensors capable of providing information regarding drug administration may be challenging due to ultralow concentrations in biofluids. This trial seeks to determine if the use of a smart wristband can accurately measure the levels of chemicals and substances in sweat.

Primary Outcome

Will be assessed by Pearson correlation and quantification of the predictive performance. The predictive performance of the home-based sampling methods will be assessed by calculating the median percentage prediction error (MPPE).

Interventions

  • PROCEDURE Biospecimen Collection
  • OTHER Questionnaire Administration
  • OTHER Medical Chart Review

Study Locations (1)

California

  • City of Hope Medical Center - Duarte

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2018-11-09
Est. Completion 2029-07-30
City of Hope Medical Center

582 total trials

What NCT04160429 shows while recruiting

NCT04160429 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 89,941-participant average among 48 other Chronic Disease trials with a reported enrollment target (100% lower).

The record links to 2 conditions, with Chronic Disease appearing as the primary indexed condition, and to 3 interventions - of which Biospecimen Collection is the first listed.

NCT04160429 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04160429 about?

NCT04160429 is a clinical study titled "Biospecimen Analysis in Detecting Chemical Concentrations in Patients With Chronic or Infectious Diseases Receiving Meditations". This trial collects and analyzes sweat and saliva samples compared to blood in detecting chemical concentrations in the body in patients with chronic or infectious diseases receiving medications. Wearable sweat sensors are capable of monitoring electrolytes and metabolites (sodium, potassium, glucos...

What is the current status of trial NCT04160429?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2018-11-09. Estimated completion is 2029-07-30.

What conditions does trial NCT04160429 study?

This clinical trial studies the following conditions: Chronic Disease, Infectious Disorder.

What interventions are being tested in trial NCT04160429?

The interventions under investigation include: Biospecimen Collection (PROCEDURE), Questionnaire Administration (OTHER), Medical Chart Review (OTHER).

Who is sponsoring clinical trial NCT04160429?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04160429 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04160429's enrollment target sits among peer trials

100 32nd of 48 higher than 16 of 48 other Chronic Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04160429, the US trial registry maintained by the National Library of Medicine. NCT04160429 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.